DOJ Intervenes in False Claims Suit, Alleges That Regeneron Violated Medicare ASP Reporting Mandates
April 11, 2024 at 10:55 AM EST
The Department of Justice (DOJ) has filed a complaint in intervention in a qui tam False Claims Act action against a pharmaceutical manufacturer, alleging that it knowingly submitting false Medicare average sales price (ASP) reports to the government (United States ex rel. Nunnelly v. Regeneron Pharmaceuticals, Inc., No. 1:20-cv-11401-PBS (D. Mass.)).
Regeneron Pharmaceutical... Read More